Combined oral contraceptive use and the risk of systemic lupus erythematosus
Authors:
Open Access
- 30 March 2009
- journal article
- systemic lupus-erythematosus
- Published by Wiley in Arthritis Care & Research
- Vol. 61 (4) , 476-481
Abstract
Objective: To assess whether the risk of incident systemic lupus erythematosus (SLE) is associated with the use of combined oral contraceptives (COCs), because studies of the link between exogenous hormonal exposure and the risk of SLE have produced conflicting results.Methods: We conducted a population‐based nested case–control study among women ages 18–45 years, using the UK's General Practice Research Database. All incident cases of SLE from 1994–2004 (n = 786) were identified in the database and matched with up to 10 controls (n = 7,817) among women without SLE at the time of the case's diagnosis.Results: The adjusted rate ratio (RR) of incident SLE associated with any use of COC was 1.19 (95% confidence interval [95% CI] 0.98–1.45), whereas with current use it was 1.54 (95% CI 1.15–2.07). The rate was particularly increased in current users who had only recently started COC use (RR 2.52, 95% CI 1.14–5.57) compared with longer‐term current users (RR 1.45, 95% CI 1.06–1.99). The risk appeared to be particularly elevated with current exposure to first‐ or second‐generation contraceptives (RR 1.65, 95% CI 1.20–2.26), and increasing with the dose of ethinyl estradiol (RR 1.42, 1.63, and 2.92 for ≤30 μg, 31–49 μg, and 50 μg, respectively).Conclusion: The use of COCs is associated with an increased risk of SLE. This risk is particularly elevated in women who recently started contraceptive use, suggesting an acute effect in a small subgroup of susceptible women.Keywords
This publication has 37 references indexed in Scilit:
- Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortLupus, 2007
- Therapy Insight: guidelines for selection of contraception in women with rheumatic diseasesNature Clinical Practice Rheumatology, 2007
- Incidence of systemic lupus erythematosus in the United Kingdom, 1990–1999Arthritis Care & Research, 2007
- Estrogens and lupus: Bubbling cauldron or another overrated Witches' Brew?Arthritis & Rheumatism, 2007
- Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activityClinical Rheumatology, 2007
- The inflammation and coagulation cross-talk in patients with systemic lupus erythematosusBlood Coagulation & Fibrinolysis, 2007
- Hormonal modulation of B cell development and repertoire selectionMolecular Immunology, 2005
- Association of the oestrogen receptor α gene polymorphisms with disease onset in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2004
- THE PREVALENCE AND INCIDENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN NOTTINGHAM, UK, 1989–1990Rheumatology, 1993
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991